Vaccine nationalism and the dynamics and control of SARS-CoV-2
Authors:
- Caroline E. WagnerCWCaroline E. Wagner
- Chadi M. Saad-RoyCSChadi M. Saad-Roy
- Sinead E. MorrisSMSinead E. Morris
- Rachel E. BakerRBRachel E. Baker
- Michael J. MinaMMMichael J. Mina
- Jeremy FarrarJFJeremy Farrar
- Edward C. HolmesEHEdward C. Holmes
- Oliver G. PybusOPOliver G. Pybus
- Andrea L. GrahamAGAndrea L. Graham
- Ezekiel J. EmanuelEEEzekiel J. Emanuel
- Simon A. LevinSLSimon A. Levin
- C. Jessica E. MetcalfCMC. Jessica E. Metcalf
Open Access
- 24 September 2021
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 373 (6562) , 1488-+
Abstract
Stockpiling and control: A triumph that has emerged from the catastrophe of the severe acute respiratory syndrome coronavirus 2 pandemic has been the rapid development of several potent vaccines. However, 18 months into the pandemic and more than 6 months after vaccine approval, wealthy countries remain the major beneficiaries. Wagner et al . model the consequences of vaccine stockpiling in affluent countries on disease rates in lower- and middle-income countries and the consequences for the eruption of new variants that could jeopardize the early success of vaccines. For countries that can readily access vaccines, it would be better to share vaccines equitably to lower disease burdens in countries with less access, reduce the cost of having to be constantly vigilant for case imports, and minimize virus evolution. —CAKeywords
All Related Versions
Funding Information
- National Science Foundation (CNS-2027908)
- National Science Foundation (CCF1917819)
- Centers for Disease Control and Prevention
- James S. McDonnell Foundation (21st Century Science Initiative Collaborative Award in Understanding Dynamic and Multi-scale Systems)
- Open Philanthropy Project
- Natural Sciences and Engineering Research Council of Canada (PGS D)
- C3.ai Digital Transformation Institute and Microsoft Corporation
- Co-operative Institute for Modelling the Earth System
- Flu Lab
This publication has 63 references indexed in Scilit:
- Viral PhylodynamicsPLOS Computational Biology, 2013
- Optimal but unequitable prophylactic distribution of vaccineEpidemics, 2012
- Synthesizing epidemiological and economic optima for control of immunizing infectionsProceedings of the National Academy of Sciences, 2011
- Adaptive human behavior in epidemiological modelsProceedings of the National Academy of Sciences, 2011
- Modelling the influence of human behaviour on the spread of infectious diseases: a reviewJournal of The Royal Society Interface, 2010
- Dynamics and Control of Diseases in Networks with Community StructurePLOS Computational Biology, 2010
- Phylodynamics of Infectious Disease EpidemicsGenetics, 2009
- Epochal Evolution Shapes the Phylodynamics of Interpandemic Influenza A (H3N2) in HumansScience, 2006
- On the definition and the computation of the basic reproduction ratio R 0 in models for infectious diseases in heterogeneous populationsJournal of Mathematical Biology, 1990
- Nonlinear Oscillations in Epidemic ModelsSIAM Journal on Applied Mathematics, 1981